15677540truethe wholesale of pharmaceutical goods2024-04-242025-04-30http://www.companieshouse.gov.uk/2024-04-23http://www.companieshouse.gov.uk/cd:Director12024-04-242025-04-30http://www.companieshouse.gov.uk/pt:ShareCapital2024-04-23http://www.companieshouse.gov.uk/pt:ShareCapital2025-04-30http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-04-242025-04-30http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-04-30http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-04-23http://www.companieshouse.gov.uk/2024-04-242025-04-30http://www.companieshouse.gov.uk/2024-04-23http://www.companieshouse.gov.uk/cd:FRS1022024-04-242025-04-30http://www.companieshouse.gov.uk/2025-04-30http://www.companieshouse.gov.uk/cd:FullAccounts2024-04-242025-04-30http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-04-242025-04-30iso4217:GBPxbrli:sharesxbrli:pure

Axunio Ltd
15677540
DORMANT ACCOUNTS
30/04/2025
						2025				2024
		Notes				£				£
CURRENT ASSETS
Debtors				100				-
Current Asset Investments				1				-
				101				-
CREDITORS: Amounts falling due within one year				1				-
NET CURRENT ASSETS						100				-
TOTAL ASSETS LESS CURRENT LIABILITIES						100				-
CAPITAL AND RESERVES
Called up share capital						100				-
SHAREHOLDERS' FUNDS						100				-
For the year ending 30/04/2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 08/01/2026 and signed on their behalf by
.............................
Richard Baderin
Director